<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-04-22" version="215">
<accession>P51149</accession>
<accession>A8K3V6</accession>
<accession>Q9NWJ0</accession>
<accession>Q9UPB0</accession>
<name>RAB7A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Ras-related protein Rab-7a</fullName>
</recommendedName>
</protein>
<gene>
<name type="primary">RAB7A</name>
<name type="synonym">RAB7</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Biochem. Biophys. Res. Commun." volume="229" first="887" last="890">
<title>Molecular cloning and expression analysis of the human Rab7 GTP-ase complementary deoxyribonucleic acid.</title>
<authorList>
<person name="Vitelli R."/>
<person name="Chiariello M."/>
<person name="Lattero D."/>
<person name="Bruni C.B."/>
<person name="Bucci C."/>
</authorList>
<dbReference type="PubMed" id="8954989"/>
<dbReference type="DOI" id="10.1006/bbrc.1996.1897"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Genomics" volume="41" first="131" last="134">
<title>Cloning and mapping of human Rab7 and Rab9 cDNA sequences and identification of a Rab9 pseudogene.</title>
<authorList>
<person name="Davies J.P."/>
<person name="Cotter P.D."/>
<person name="Ioannou Y.A."/>
</authorList>
<dbReference type="PubMed" id="9126495"/>
<dbReference type="DOI" id="10.1006/geno.1997.4644"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="1998-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Kim J.Y."/>
<person name="Park Y.B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2002-04" db="EMBL/GenBank/DDBJ databases">
<title>cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).</title>
<authorList>
<person name="Puhl H.L. III"/>
<person name="Ikeda S.R."/>
<person name="Aronstam R.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="683" last="693">
<title>Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes.</title>
<authorList>
<person name="Cantalupo G."/>
<person name="Alifano P."/>
<person name="Roberti V."/>
<person name="Bruni C.B."/>
<person name="Bucci C."/>
</authorList>
<dbReference type="PubMed" id="11179213"/>
<dbReference type="DOI" id="10.1093/emboj/20.4.683"/>
</citation>
<scope>FUNCTION IN LATE ENDOCYTOSIS</scope>
<scope>INTERACTION WITH RILP</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Proteome Res." volume="2" first="69" last="79">
<title>Proteomic analysis of early melanosomes: identification of novel melanosomal proteins.</title>
<authorList>
<person name="Basrur V."/>
<person name="Yang F."/>
<person name="Kushimoto T."/>
<person name="Higashimoto Y."/>
<person name="Yasumoto K."/>
<person name="Valencia J."/>
<person name="Muller J."/>
<person name="Vieira W.D."/>
<person name="Watabe H."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Hunt D.F."/>
<person name="Appella E."/>
</authorList>
<dbReference type="PubMed" id="12643545"/>
<dbReference type="DOI" id="10.1021/pr025562r"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="6494" last="6506">
<title>Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP.</title>
<authorList>
<person name="Harrison R.E."/>
<person name="Bucci C."/>
<person name="Vieira O.V."/>
<person name="Schroer T.A."/>
<person name="Grinstein S."/>
</authorList>
<dbReference type="PubMed" id="12944476"/>
<dbReference type="DOI" id="10.1128/mcb.23.18.6494-6506.2003"/>
</citation>
<scope>FUNCTION IN PHAGOSOMAL BIOGENESIS</scope>
<scope>MUTAGENESIS OF THR-22 AND GLN-67</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Traffic" volume="4" first="754" last="771">
<title>Human VPS34 and p150 are Rab7 interacting partners.</title>
<authorList>
<person name="Stein M.P."/>
<person name="Feng Y."/>
<person name="Cooper K.L."/>
<person name="Welford A.M."/>
<person name="Wandinger-Ness A."/>
</authorList>
<dbReference type="PubMed" id="14617358"/>
<dbReference type="DOI" id="10.1034/j.1600-0854.2003.00133.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PIK3C3/VPS34-PIK3R4 COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="21334" last="21342">
<title>The proteasome alpha-subunit XAPC7 interacts specifically with Rab7 and late endosomes.</title>
<authorList>
<person name="Dong J."/>
<person name="Chen W."/>
<person name="Welford A."/>
<person name="Wandinger-Ness A."/>
</authorList>
<dbReference type="PubMed" id="14998988"/>
<dbReference type="DOI" id="10.1074/jbc.m401022200"/>
</citation>
<scope>INTERACTION WITH PSMA7</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Mol. Biol. Cell" volume="15" first="815" last="826">
<title>A unique region of RILP distinguishes it from its related proteins in its regulation of lysosomal morphology and interaction with Rab7 and Rab34.</title>
<authorList>
<person name="Wang T."/>
<person name="Wong K.K."/>
<person name="Hong W."/>
</authorList>
<dbReference type="PubMed" id="14668488"/>
<dbReference type="DOI" id="10.1091/mbc.e03-06-0413"/>
</citation>
<scope>INTERACTION WITH RILP</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="5480" last="5492">
<title>The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments.</title>
<authorList>
<person name="Johansson M."/>
<person name="Lehto M."/>
<person name="Tanhuanpaeae K."/>
<person name="Cover T.L."/>
<person name="Olkkonen V.M."/>
</authorList>
<dbReference type="PubMed" id="16176980"/>
<dbReference type="DOI" id="10.1091/mbc.e05-03-0189"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH OSBPL1A</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
<title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
<authorList>
<person name="Chi A."/>
<person name="Valencia J.C."/>
<person name="Hu Z.-Z."/>
<person name="Watabe H."/>
<person name="Yamaguchi H."/>
<person name="Mangini N.J."/>
<person name="Huang H."/>
<person name="Canfield V.A."/>
<person name="Cheng K.C."/>
<person name="Yang F."/>
<person name="Abe R."/>
<person name="Yamagishi S."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Wu C."/>
<person name="Appella E."/>
<person name="Hunt D.F."/>
</authorList>
<dbReference type="PubMed" id="17081065"/>
<dbReference type="DOI" id="10.1021/pr060363j"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Neoplasia" volume="8" first="689" last="695">
<title>Novel RING E3 ubiquitin ligases in breast cancer.</title>
<authorList>
<person name="Burger A."/>
<person name="Amemiya Y."/>
<person name="Kitching R."/>
<person name="Seth A.K."/>
</authorList>
<dbReference type="PubMed" id="16925951"/>
<dbReference type="DOI" id="10.1593/neo.06469"/>
</citation>
<scope>INTERACTION WITH RNF115</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Biosci. Rep." volume="29" first="193" last="209">
<title>Rab7: roles in membrane trafficking and disease.</title>
<authorList>
<person name="Zhang M."/>
<person name="Chen L."/>
<person name="Wang S."/>
<person name="Wang T."/>
</authorList>
<dbReference type="PubMed" id="19392663"/>
<dbReference type="DOI" id="10.1042/bsr20090032"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="7794" last="7804">
<title>Assembly of the biogenesis of lysosome-related organelles complex-3 (BLOC-3) and its interaction with Rab9.</title>
<authorList>
<person name="Kloer D.P."/>
<person name="Rojas R."/>
<person name="Ivan V."/>
<person name="Moriyama K."/>
<person name="van Vlijmen T."/>
<person name="Murthy N."/>
<person name="Ghirlando R."/>
<person name="van der Sluijs P."/>
<person name="Hurley J.H."/>
<person name="Bonifacino J.S."/>
</authorList>
<dbReference type="PubMed" id="20048159"/>
<dbReference type="DOI" id="10.1074/jbc.m109.069088"/>
</citation>
<scope>LACK OF INTERACTION WITH HPS4 AND THE BLOC-3 COMPLEX</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="J. Cell Biol." volume="188" first="253" last="269">
<title>FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport.</title>
<authorList>
<person name="Pankiv S."/>
<person name="Alemu E.A."/>
<person name="Brech A."/>
<person name="Bruun J.A."/>
<person name="Lamark T."/>
<person name="Overvatn A."/>
<person name="Bjorkoy G."/>
<person name="Johansen T."/>
</authorList>
<dbReference type="PubMed" id="20100911"/>
<dbReference type="DOI" id="10.1083/jcb.200907015"/>
</citation>
<scope>INTERACTION WITH FYCO1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2011" name="Cell. Signal." volume="23" first="516" last="521">
<title>Rab7: role of its protein interaction cascades in endo-lysosomal traffic.</title>
<authorList>
<person name="Wang T."/>
<person name="Ming Z."/>
<person name="Xiaochun W."/>
<person name="Hong W."/>
</authorList>
<dbReference type="PubMed" id="20851765"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2010.09.012"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="Traffic" volume="12" first="407" last="420">
<title>Rab GTPases regulating phagosome maturation are differentially recruited to mycobacterial phagosomes.</title>
<authorList>
<person name="Seto S."/>
<person name="Tsujimura K."/>
<person name="Koide Y."/>
</authorList>
<dbReference type="PubMed" id="21255211"/>
<dbReference type="DOI" id="10.1111/j.1600-0854.2011.01165.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Cell. Mol. Life Sci." volume="69" first="2075" last="2089">
<title>Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments.</title>
<authorList>
<person name="Uusi-Rauva K."/>
<person name="Kyttala A."/>
<person name="van der Kant R."/>
<person name="Vesa J."/>
<person name="Tanhuanpaa K."/>
<person name="Neefjes J."/>
<person name="Olkkonen V.M."/>
<person name="Jalanko A."/>
</authorList>
<dbReference type="PubMed" id="22261744"/>
<dbReference type="DOI" id="10.1007/s00018-011-0913-1"/>
</citation>
<scope>INTERACTION WITH CLN3</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="Mol. Cell. Biol." volume="32" first="1855" last="1866">
<title>The role of ceroid lipofuscinosis neuronal protein 5 (CLN5) in endosomal sorting.</title>
<authorList>
<person name="Mamo A."/>
<person name="Jules F."/>
<person name="Dumaresq-Doiron K."/>
<person name="Costantino S."/>
<person name="Lefrancois S."/>
</authorList>
<dbReference type="PubMed" id="22431521"/>
<dbReference type="DOI" id="10.1128/mcb.06726-11"/>
</citation>
<scope>INTERACTION WITH CLN5 AND RILP</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF THR-22 AND GLN-67</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Nat. Cell Biol." volume="14" first="677" last="685">
<title>Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.</title>
<authorList>
<person name="Baietti M.F."/>
<person name="Zhang Z."/>
<person name="Mortier E."/>
<person name="Melchior A."/>
<person name="Degeest G."/>
<person name="Geeraerts A."/>
<person name="Ivarsson Y."/>
<person name="Depoortere F."/>
<person name="Coomans C."/>
<person name="Vermeiren E."/>
<person name="Zimmermann P."/>
<person name="David G."/>
</authorList>
<dbReference type="PubMed" id="22660413"/>
<dbReference type="DOI" id="10.1038/ncb2502"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="Acta Neuropathol." volume="125" first="257" last="272">
<title>Charcot-Marie-Tooth type 2B disease-causing RAB7A mutant proteins show altered interaction with the neuronal intermediate filament peripherin.</title>
<authorList>
<person name="Cogli L."/>
<person name="Progida C."/>
<person name="Thomas C.L."/>
<person name="Spencer-Dene B."/>
<person name="Donno C."/>
<person name="Schiavo G."/>
<person name="Bucci C."/>
</authorList>
<dbReference type="PubMed" id="23179371"/>
<dbReference type="DOI" id="10.1007/s00401-012-1063-8"/>
</citation>
<scope>INTERACTION WITH PRPH</scope>
<scope>CHARACTERIZATION OF VARIANTS CMT2B PHE-129; ASN-157; THR-161 AND MET-162</scope>
<scope>MUTAGENESIS OF THR-22 AND GLN-67</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2015" name="J. Cell Biol." volume="210" first="1133" last="1152">
<title>RUN and FYVE domain-containing protein 4 enhances autophagy and lysosome tethering in response to Interleukin-4.</title>
<authorList>
<person name="Terawaki S."/>
<person name="Camosseto V."/>
<person name="Prete F."/>
<person name="Wenger T."/>
<person name="Papadopoulos A."/>
<person name="Rondeau C."/>
<person name="Combes A."/>
<person name="Rodriguez Rodrigues C."/>
<person name="Vu Manh T.P."/>
<person name="Fallet M."/>
<person name="English L."/>
<person name="Santamaria R."/>
<person name="Soares A.R."/>
<person name="Weil T."/>
<person name="Hammad H."/>
<person name="Desjardins M."/>
<person name="Gorvel J.P."/>
<person name="Santos M.A."/>
<person name="Gatti E."/>
<person name="Pierre P."/>
</authorList>
<dbReference type="PubMed" id="26416964"/>
<dbReference type="DOI" id="10.1083/jcb.201501059"/>
</citation>
<scope>INTERACTION WITH RUFY4</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="1491" last="1501">
<title>Structural basis for recruitment of RILP by small GTPase Rab7.</title>
<authorList>
<person name="Wu M."/>
<person name="Wang T."/>
<person name="Loh E."/>
<person name="Hong W."/>
<person name="Song H."/>
</authorList>
<dbReference type="PubMed" id="15933719"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600643"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH GTP AND RILP</scope>
<scope>MUTAGENESIS OF LEU-8; LYS-10; VAL-180; LEU-182 AND TYR-183</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Hum. Mol. Genet." volume="19" first="1033" last="1047">
<title>Disease mutations in Rab7 result in unregulated nucleotide exchange and inappropriate activation.</title>
<authorList>
<person name="McCray B.A."/>
<person name="Skordalakes E."/>
<person name="Taylor J.P."/>
</authorList>
<dbReference type="PubMed" id="20028791"/>
<dbReference type="DOI" id="10.1093/hmg/ddp567"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF VARIANT CMT2B PHE-129 IN COMPLEX WITH GTP</scope>
<scope>CHARACTERIZATION OF VARIANTS CMT2B PHE-129 AND MET-162</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2003" name="Am. J. Hum. Genet." volume="72" first="722" last="727">
<title>Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy.</title>
<authorList>
<person name="Verhoeven K."/>
<person name="De Jonghe P."/>
<person name="Coen K."/>
<person name="Verpoorten N."/>
<person name="Auer-Grumbach M."/>
<person name="Kwon J.M."/>
<person name="FitzPatrick D."/>
<person name="Schmedding E."/>
<person name="De Vriendt E."/>
<person name="Jacobs A."/>
<person name="Van Gerwen V."/>
<person name="Wagner K."/>
<person name="Hartung H.-P."/>
<person name="Timmerman V."/>
</authorList>
<dbReference type="PubMed" id="12545426"/>
<dbReference type="DOI" id="10.1086/367847"/>
</citation>
<scope>VARIANTS CMT2B PHE-129 AND MET-162</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2004" name="Ann. Neurol." volume="56" first="586" last="590">
<title>A novel RAB7 mutation associated with ulcero-mutilating neuropathy.</title>
<authorList>
<person name="Houlden H."/>
<person name="King R.H.M."/>
<person name="Muddle J.R."/>
<person name="Warner T.T."/>
<person name="Reilly M.M."/>
<person name="Orrell R.W."/>
<person name="Ginsberg L."/>
</authorList>
<dbReference type="PubMed" id="15455439"/>
<dbReference type="DOI" id="10.1002/ana.20281"/>
</citation>
<scope>VARIANT CMT2B THR-161</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2006" name="Neurology" volume="67" first="1476" last="1478">
<title>Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene.</title>
<authorList>
<person name="Meggouh F."/>
<person name="Bienfait H.M.E."/>
<person name="Weterman M.A.J."/>
<person name="de Visser M."/>
<person name="Baas F."/>
</authorList>
<dbReference type="PubMed" id="17060578"/>
<dbReference type="DOI" id="10.1212/01.wnl.0000240068.21499.f5"/>
</citation>
<scope>VARIANT CMT2B ASN-157</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E15351" last="E15351">
<title>Rab7 mutants associated with Charcot-Marie-Tooth disease exhibit enhanced NGF-stimulated signaling.</title>
<authorList>
<person name="Basuray S."/>
<person name="Mukherjee S."/>
<person name="Romero E."/>
<person name="Wilson M.C."/>
<person name="Wandinger-Ness A."/>
</authorList>
<dbReference type="PubMed" id="21151572"/>
<dbReference type="DOI" id="10.1371/journal.pone.0015351"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CMT2B PHE-129; ASN-157; THR-161 AND MET-162</scope>
</reference>
<comment type="function">
<text evidence="9 10 13 14 23 30">Key regulator in endo-lysosomal trafficking. Governs early-to-late endosomal maturation, microtubule minus-end as well as plus-end directed endosomal migration and positioning, and endosome-lysosome transport through different protein-protein interaction cascades. Plays a central role, not only in endosomal traffic, but also in many other cellular and physiological events, such as growth-factor-mediated cell signaling, nutrient-transportor mediated nutrient uptake, neurotrophin transport in the axons of neurons and lipid metabolism. Also involved in regulation of some specialized endosomal membrane trafficking, such as maturation of melanosomes, pathogen-induced phagosomes (or vacuoles) and autophagosomes. Plays a role in the maturation and acidification of phagosomes that engulf pathogens, such as S.aureus and M.tuberculosis. Plays a role in the fusion of phagosomes with lysosomes. Plays important roles in microbial pathogen infection and survival, as well as in participating in the life cycle of viruses. Microbial pathogens possess survival strategies governed by RAB7A, sometimes by employing RAB7A function (e.g. Salmonella) and sometimes by excluding RAB7A function (e.g. Mycobacterium). In concert with RAC1, plays a role in regulating the formation of RBs (ruffled borders) in osteoclasts. Controls the endosomal trafficking and neurite outgrowth signaling of NTRK1/TRKA (PubMed:11179213, PubMed:12944476, PubMed:14617358, PubMed:20028791, PubMed:21255211). Regulates the endocytic trafficking of the EGF-EGFR complex by regulating its lysosomal degradation. Involved in the ADRB2-stimulated lipolysis through lipophagy, a cytosolic lipase-independent autophagic pathway (By similarity). Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). May play a role in PRPH neuronal intermediate filament assembly (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="8 9 10 14 15 16 18 19 20 23 24 25 28 29 31 32">The GTP-bound form interacts with RAC1 (By similarity). Interacts with NTRK1/TRKA (By similarity). Interacts with C9orf72 (By similarity). Interacts with CHM, the substrate-binding subunit of the Rab geranylgeranyltransferase complex (By similarity). Interacts with RILP (PubMed:11179213, PubMed:14668488, PubMed:15933719, PubMed:20028791, PubMed:22431521). Interacts with PSMA7 (PubMed:14998988). Interacts with RNF115 (PubMed:16925951). Interacts with FYCO1 (PubMed:20100911). Interacts with the PIK3C3/VPS34-PIK3R4 complex (PubMed:14617358). The GTP-bound form interacts with OSBPL1A (PubMed:16176980). Interacts with CLN3 (PubMed:22261744). Does not interact with HPS4 and the BLOC-3 complex (heterodimer of HPS1 and HPS4) (PubMed:20048159). Interacts with CLN5 (PubMed:22431521). Interacts with PLEKHM1 (via N- and C-terminus) (By similarity). Interacts with RUFY4 (PubMed:26416964). Interacts with PRPH; the interaction is direct (PubMed:23179371).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1056089">
<id>P51149</id>
</interactant>
<interactant intactId="EBI-2856119">
<id>Q96NA2</id>
<label>RILP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 27">Cytoplasmic vesicle</location>
<location evidence="13 27">Phagosome membrane</location>
<topology evidence="33">Peripheral membrane protein</topology>
<orientation evidence="33">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="13 14 19 23">Late endosome membrane</location>
<topology evidence="33">Peripheral membrane protein</topology>
<orientation evidence="33">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="13 23">Lysosome membrane</location>
<topology evidence="33">Peripheral membrane protein</topology>
<orientation evidence="33">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="12 22">Melanosome membrane</location>
<topology evidence="33">Peripheral membrane protein</topology>
<orientation evidence="33">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="23">Cytoplasmic vesicle</location>
<location evidence="23">Autophagosome membrane</location>
<topology evidence="33">Peripheral membrane protein</topology>
<orientation evidence="33">Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Lipid droplet</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="29">Endosome membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="9">Cytoplasmic vesicle</location>
</subcellularLocation>
<text evidence="9 19 27">Colocalizes with OSBPL1A at the late endosome (PubMed:16176980). Found in the ruffled border (a late endosomal-like compartment in the plasma membrane) of bone-resorbing osteoclasts. Recruited to phagosomes containing S.aureus or Mycobacterium (PubMed:21255211). Lipid droplet localization is increased upon ADRB2 stimulation (By similarity).</text>
</comment>
<comment type="tissue specificity">
<text evidence="11">Widely expressed; high expression found in skeletal muscle.</text>
</comment>
<comment type="disease" evidence="11 17 21 23 26 31">
<disease id="DI-00276">
<name>Charcot-Marie-Tooth disease 2B</name>
<acronym>CMT2B</acronym>
<description>A dominant axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.</description>
<dbReference type="MIM" id="600882"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="33">Belongs to the small GTPase superfamily. Rab family.</text>
</comment>
<comment type="sequence caution" evidence="33">
<conflict type="erroneous translation">
<sequence resource="EMBL-CDS" id="BAA91390" version="1"/>
</conflict>
<text>Wrong choice of frame.</text>
</comment>
<comment type="sequence caution" evidence="33">
<conflict type="erroneous translation">
<sequence resource="EMBL-CDS" id="BAF83410" version="1"/>
</conflict>
<text>Wrong choice of frame.</text>
</comment>
<comment type="sequence caution" evidence="33">
<conflict type="erroneous gene model prediction">
<sequence resource="EMBL-CDS" id="EAW79303" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Inherited peripheral neuropathies mutation db">
<link uri="https://uantwerpen.vib.be/CMTMutations"/>
</comment>
<comment type="online information" name="Leiden Muscular Dystrophy pages RAB7A, member RAS oncogene family (RAB7A)">
<link uri="https://databases.lovd.nl/shared/genes/RAB7A"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EMBL" id="X93499">
<property type="protein sequence ID" value="CAA63763.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U44104">
<property type="protein sequence ID" value="AAA86640.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF050175">
<property type="protein sequence ID" value="AAD02565.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF498942">
<property type="protein sequence ID" value="AAM21090.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK000826">
<property type="protein sequence ID" value="BAA91390.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290721">
<property type="protein sequence ID" value="BAF83410.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008721">
<property type="protein sequence ID" value="AAH08721.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471052">
<property type="protein sequence ID" value="EAW79303.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS3052.1"/>
<dbReference type="PIR" id="JC5268">
<property type="entry name" value="JC5268"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004628.4">
<property type="nucleotide sequence ID" value="NM_004637.5"/>
</dbReference>
<dbReference type="PDB" id="1T91">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=1-207"/>
</dbReference>
<dbReference type="PDB" id="1YHN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=1-207"/>
</dbReference>
<dbReference type="PDB" id="3LAW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D/E=1-207"/>
</dbReference>
<dbReference type="PDB" id="6IYB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A/C=2-195"/>
</dbReference>
<dbReference type="PDBsum" id="1T91"/>
<dbReference type="PDBsum" id="1YHN"/>
<dbReference type="PDBsum" id="3LAW"/>
<dbReference type="PDBsum" id="6IYB"/>
<dbReference type="SMR" id="P51149"/>
<dbReference type="BioGrid" id="113624">
<property type="interactions" value="266"/>
</dbReference>
<dbReference type="DIP" id="DIP-39879N"/>
<dbReference type="IntAct" id="P51149">
<property type="interactions" value="118"/>
</dbReference>
<dbReference type="MINT" id="P51149"/>
<dbReference type="STRING" id="9606.ENSP00000265062"/>
<dbReference type="ChEMBL" id="CHEMBL4105784"/>
<dbReference type="DrugBank" id="DB04315">
<property type="generic name" value="Guanosine-5'-Diphosphate"/>
</dbReference>
<dbReference type="TCDB" id="9.A.3.1.1">
<property type="family name" value="the sorting nexin27 (snx27)-retromer assembly apparatus"/>
</dbReference>
<dbReference type="iPTMnet" id="P51149"/>
<dbReference type="PhosphoSitePlus" id="P51149"/>
<dbReference type="SwissPalm" id="P51149"/>
<dbReference type="BioMuta" id="RAB7A"/>
<dbReference type="DMDM" id="1709999"/>
<dbReference type="EPD" id="P51149"/>
<dbReference type="jPOST" id="P51149"/>
<dbReference type="MassIVE" id="P51149"/>
<dbReference type="MaxQB" id="P51149"/>
<dbReference type="PaxDb" id="P51149"/>
<dbReference type="PeptideAtlas" id="P51149"/>
<dbReference type="PRIDE" id="P51149"/>
<dbReference type="ProteomicsDB" id="56284"/>
<dbReference type="TopDownProteomics" id="P51149"/>
<dbReference type="Antibodypedia" id="1885">
<property type="antibodies" value="343 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7879"/>
<dbReference type="Ensembl" id="ENST00000265062">
<property type="protein sequence ID" value="ENSP00000265062"/>
<property type="gene ID" value="ENSG00000075785"/>
</dbReference>
<dbReference type="GeneID" id="7879"/>
<dbReference type="KEGG" id="hsa:7879"/>
<dbReference type="UCSC" id="uc003eks.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7879"/>
<dbReference type="DisGeNET" id="7879"/>
<dbReference type="GeneCards" id="RAB7A"/>
<dbReference type="GeneReviews" id="RAB7A"/>
<dbReference type="HGNC" id="HGNC:9788">
<property type="gene designation" value="RAB7A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000075785">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="RAB7A"/>
<dbReference type="MIM" id="600882">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="602298">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P51149"/>
<dbReference type="OpenTargets" id="ENSG00000075785"/>
<dbReference type="Orphanet" id="99936">
<property type="disease" value="Autosomal dominant Charcot-Marie-Tooth disease type 2B"/>
</dbReference>
<dbReference type="PharmGKB" id="PA162400619"/>
<dbReference type="eggNOG" id="KOG0394">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNZV">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155864"/>
<dbReference type="InParanoid" id="P51149"/>
<dbReference type="KO" id="K07897"/>
<dbReference type="OMA" id="DGDNCAC"/>
<dbReference type="OrthoDB" id="1172019at2759"/>
<dbReference type="PhylomeDB" id="P51149"/>
<dbReference type="TreeFam" id="TF105605"/>
<dbReference type="Reactome" id="R-HSA-2132295">
<property type="pathway name" value="MHC class II antigen presentation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6798695">
<property type="pathway name" value="Neutrophil degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854214">
<property type="pathway name" value="TBC/RABGAPs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8873719">
<property type="pathway name" value="RAB geranylgeranylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8876198">
<property type="pathway name" value="RAB GEFs exchange GTP for GDP on RABs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9636383">
<property type="pathway name" value="Prevention of phagosomal-lysosomal fusion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9636569">
<property type="pathway name" value="Suppression of autophagy"/>
</dbReference>
<dbReference type="SignaLink" id="P51149"/>
<dbReference type="ChiTaRS" id="RAB7A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P51149"/>
<dbReference type="GeneWiki" id="RAB7A"/>
<dbReference type="GenomeRNAi" id="7879"/>
<dbReference type="Pharos" id="P51149">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P51149"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="P51149">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000075785">
<property type="expression patterns" value="Expressed in frontal cortex and 232 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P51149">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P51149">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000421">
<property type="term" value="C:autophagosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005623">
<property type="term" value="C:cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0012505">
<property type="term" value="C:endomembrane system"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032419">
<property type="term" value="C:extrinsic component of lysosome membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005770">
<property type="term" value="C:late endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031902">
<property type="term" value="C:late endosome membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005811">
<property type="term" value="C:lipid droplet"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005765">
<property type="term" value="C:lysosomal membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0033162">
<property type="term" value="C:melanosome membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0045335">
<property type="term" value="C:phagocytic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030670">
<property type="term" value="C:phagocytic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0034045">
<property type="term" value="C:phagophore assembly site membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030667">
<property type="term" value="C:secretory granule membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019003">
<property type="term" value="F:GDP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005525">
<property type="term" value="F:GTP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003924">
<property type="term" value="F:GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905394">
<property type="term" value="F:retromer complex binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019886">
<property type="term" value="P:antigen processing and presentation of exogenous peptide antigen via MHC class II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000045">
<property type="term" value="P:autophagosome assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045022">
<property type="term" value="P:early endosome to late endosome transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006897">
<property type="term" value="P:endocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008333">
<property type="term" value="P:endosome to lysosome transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007174">
<property type="term" value="P:epidermal growth factor catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051650">
<property type="term" value="P:establishment of vesicle localization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006886">
<property type="term" value="P:intracellular protein transport"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016042">
<property type="term" value="P:lipid catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0061724">
<property type="term" value="P:lipophagy"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1902586">
<property type="term" value="P:multi-organism intercellular transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903542">
<property type="term" value="P:negative regulation of exosomal secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905366">
<property type="term" value="P:negative regulation of intralumenal vesicle formation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043312">
<property type="term" value="P:neutrophil degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0090383">
<property type="term" value="P:phagosome acidification"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090382">
<property type="term" value="P:phagosome maturation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090385">
<property type="term" value="P:phagosome-lysosome fusion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903543">
<property type="term" value="P:positive regulation of exosomal secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045732">
<property type="term" value="P:positive regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0048524">
<property type="term" value="P:positive regulation of viral process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="GO" id="GO:0006622">
<property type="term" value="P:protein targeting to lysosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0022615">
<property type="term" value="P:protein to membrane docking"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015031">
<property type="term" value="P:protein transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032482">
<property type="term" value="P:Rab protein signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042147">
<property type="term" value="P:retrograde transport, endosome to Golgi"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019076">
<property type="term" value="P:viral release from host cell"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CACAO"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR005225">
<property type="entry name" value="Small_GTP-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001806">
<property type="entry name" value="Small_GTPase"/>
</dbReference>
<dbReference type="Pfam" id="PF00071">
<property type="entry name" value="Ras"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00231">
<property type="entry name" value="small_GTP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51419">
<property type="entry name" value="RAB"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0144">Charcot-Marie-Tooth disease</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0342">GTP-binding</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0442">Lipid degradation</keyword>
<keyword id="KW-0551">Lipid droplet</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0636">Prenylation</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="initiator methionine" description="Removed" evidence="6">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Ras-related protein Rab-7a" id="PRO_0000121121">
<location>
<begin position="2"/>
<end position="207"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="18 23">
<location>
<begin position="15"/>
<end position="22"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="18 23">
<location>
<begin position="34"/>
<end position="40"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="18 23">
<location>
<begin position="63"/>
<end position="67"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="18 23">
<location>
<begin position="125"/>
<end position="128"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="GTP" evidence="18 23">
<location>
<begin position="156"/>
<end position="157"/>
</location>
</feature>
<feature type="short sequence motif" description="Effector region" evidence="7">
<location>
<begin position="37"/>
<end position="45"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylthreonine" evidence="6">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 5">
<location>
<position position="72"/>
</location>
</feature>
<feature type="modified residue" description="Cysteine methyl ester" evidence="7">
<location>
<position position="207"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-geranylgeranyl cysteine" evidence="7">
<location>
<position position="205"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-geranylgeranyl cysteine" evidence="7">
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11549759." id="VAR_037886">
<original>K</original>
<variation>E</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2B; increases GTP hydrolysis; decreases affinity for GTP and GDP; does not affect interaction with NTRK1; results in higher levels of NTRK1 and MAPK1/MAPK3 phosphorylation after NGF stimulation consistent with enhanced MAPK signaling; increases interaction with PRPH; dbSNP:rs121909078." id="VAR_018722" evidence="11 23 26 31">
<original>L</original>
<variation>F</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2B; does not affect interaction with NTRK1; results in higher levels of NTRK1 and MAPK1/MAPK3 phosphorylation after NGF stimulation consistent with enhanced MAPK signaling; increases interaction with PRPH; dbSNP:rs121909081." id="VAR_037887" evidence="21 26 31">
<original>K</original>
<variation>N</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2B; does not affect interaction with NTRK1; results in higher levels of NTRK1 and MAPK1/MAPK3 phosphorylation after NGF stimulation consistent with enhanced MAPK signaling; increases interaction with PRPH; dbSNP:rs121909080." id="VAR_037888" evidence="17 26 31">
<original>N</original>
<variation>T</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2B; increases GTP hydrolysis; decreases affinity for GTP and GDP; does not affect interaction with NTRK1; results in higher levels of NTRK1 and MAPK1/MAPK3 phosphorylation after NGF stimulation consistent with enhanced MAPK signaling; increases interaction with PRPH; dbSNP:rs121909079." id="VAR_018723" evidence="11 23 26 31">
<original>V</original>
<variation>M</variation>
<location>
<position position="162"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RILP and reduces its localization to late endosomal/lysosomal compartments." evidence="18">
<original>L</original>
<variation>A</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments." evidence="18">
<original>K</original>
<variation>A</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes localization on late endosomes, lysosomes and phagosomes and reduces phagosomal fusions. Abolishes association of RILP with the phagosomes. No loss of interaction with CLN5. No loss of interaction with PRPH." evidence="13 29 31">
<original>T</original>
<variation>N</variation>
<location>
<position position="22"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish localization on late endosomes, lysosomes and phagosomes and does not reduce phagosomal fusions. No loss of interaction with CLN5. Increases interaction with PRPH." evidence="13 29 31">
<original>Q</original>
<variation>L</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with RILP and localization to late endosomal/lysosomal compartments." evidence="18">
<original>V</original>
<variation>A</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments; when associated with A-183." evidence="18">
<original>L</original>
<variation>A</variation>
<location>
<position position="182"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments. Does not abolish interaction with RILP and localization to late endosomal/lysosomal compartments; when associated with A-182." evidence="18">
<original>Y</original>
<variation>A</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAD02565." ref="3" evidence="33">
<original>T</original>
<variation>I</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA86640." ref="2" evidence="33">
<original>I</original>
<variation>V</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA86640." ref="2" evidence="33">
<original>I</original>
<variation>V</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAD02565." ref="3" evidence="33">
<original>V</original>
<variation>E</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="8"/>
<end position="14"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="21"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="42"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="56"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="68"/>
<end position="70"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="76"/>
<end position="78"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="82"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="93"/>
<end position="97"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="99"/>
<end position="110"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="115"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="120"/>
<end position="125"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="129"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="136"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="151"/>
<end position="153"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="156"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="162"/>
<end position="181"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1T91"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6IYB"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P09527"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P51150"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11179213"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12545426"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12643545"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12944476"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14617358"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14668488"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14998988"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15455439"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15933719"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16176980"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16925951"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17060578"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17081065"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20028791"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20048159"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20100911"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21151572"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21255211"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22261744"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22431521"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22660413"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23179371"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26416964"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000305"/>
<sequence length="207" mass="23490" checksum="A2AF33B16A672971" modified="1996-10-01" version="1">MTSRKKVLLKVIILGDSGVGKTSLMNQYVNKKFSNQYKATIGADFLTKEVMVDDRLVTMQIWDTAGQERFQSLGVAFYRGADCCVLVFDVTAPNTFKTLDSWRDEFLIQASPRDPENFPFVVLGNKIDLENRQVATKRAQAWCYSKNNIPYFETSAKEAINVEQAFQTIARNALKQETEVELYNEFPEPIKLDKNDRAKASAESCSC</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>